Newsletter Subscription

Food and Drug Administration (FDA) Releases a draft five-year Plan for Rare Diseases.

Sep 28, 2011

The FDA has released a draft five-year plan for fostering rare disease drug development and help drug makers interested in developing treatments for the diseases. Training of biotech companies and outreach to the many stakeholders involved will be conducted as outlined in the report that you can read here.

BILAT-USA (Grant Agreement no: 244434) and Link2US (Grant Agreement no: 244371) Projects are co-funded by the European Union’s Capacities Programme on International Cooperation under the 7th Framework Programme for Research and Technological Cooperation.